EUVIMEDEUVIMED entdecken
Open Access

Switching from sulphasalazine or oral 5-aminosalicylic acid to another oral 5-aminosalicylic acid drug in the maintenance of remission in ulcerative colitis

Osama Abed iD, Andreas Hallan iD, Mie Micheelsen Norlén iD, Lars Koch Hansen iD, Mette Munk Lauridsen iD, Maiken Thyregod Jørgensen, Jens Kjeldsen iD

Cochrane Database of Systematic Reviews · 27.07.2026 · 2026 (7)

DOI: 10.1002/14651858.cd016374 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cochrane Database of Systematic Reviews, online erschienen am 27.07.2026. Verfasst von Osama Abed und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Gastroenterology, Lillebaelt Hospital, Vejle, Denmark. Hauptthemen laut MEDLINE: Anti-Inflammatory Agents, Non-Steroidal, Colitis, Ulcerative, Drug Substitution, Mesalamine. Die Arbeit nennt 46 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Anti-Inflammatory Agents, Non-SteroidalColitis, UlcerativeDrug SubstitutionMesalamineSulfasalazineHumansAdministration, OralMaintenance ChemotherapyRandomized Controlled Trials as TopicRemission InductionSystematic Reviews as TopicResearch Design

Substanzen

Anti-Inflammatory Agents, Non-SteroidalMesalamineSulfasalazine

Autor:innen und Institutionen

  • Department of Gastroenterology, Lillebaelt Hospital, Vejle, Denmark.
  • Medical Department, Levanger Hospital, Levanger, Norway.
  • Department of Gastroenterology, Esbjerg and Grindsted Hospital, Esbjerg, Denmark.
  • Department of Medical Gastrointestinal Diseases, Odense University Hospital, Odense, Denmark.

ORCID-Profile: Osama Abed, Andreas Hallan, Mie Micheelsen Norlén, Lars Koch Hansen, Mette Munk Lauridsen, Jens Kjeldsen

Zitieren

APA

Abed, O., Hallan, A., Norlén, M. M., Koch Hansen, L., Munk Lauridsen, M., Jørgensen, M. T., & Kjeldsen, J. (2026). Switching from sulphasalazine or oral 5-aminosalicylic acid to another oral 5-aminosalicylic acid drug in the maintenance of remission in ulcerative colitis. Cochrane Database of Systematic Reviews, 2026(7). https://doi.org/10.1002/14651858.cd016374

Vancouver

Abed O, Hallan A, Norlén MM, Koch Hansen L, Munk Lauridsen M, Jørgensen MT, et al. Switching from sulphasalazine or oral 5-aminosalicylic acid to another oral 5-aminosalicylic acid drug in the maintenance of remission in ulcerative colitis. Cochrane Database of Systematic Reviews. 2026;2026(7). doi:10.1002/14651858.cd016374

BibTeX
@article{Abed2026,
  author = {Abed, Osama and Hallan, Andreas and Norlén, Mie Micheelsen and Koch Hansen, Lars and Munk Lauridsen, Mette and Jørgensen, Maiken Thyregod and Kjeldsen, Jens},
  title = {Switching from sulphasalazine or oral 5-aminosalicylic acid to another oral 5-aminosalicylic acid drug in the maintenance of remission in ulcerative colitis},
  journal = {Cochrane Database of Systematic Reviews},
  year = {2026},
  volume = {2026},
  number = {7},
  doi = {10.1002/14651858.cd016374}
}
Kostenlos starten →